About

Frank Engel Rasmussen, PhD, is Director of Business Development at MGS. He is a highly experienced business development leader with more than two decades of experience across pharmaceutical, diagnostic and medical technology product development, drug delivery systems and healthcare manufacturing. Blending deep technical fluency with strong commercial execution, Dr Rasmussen leads strategic initiatives to grow MGS’ presence in the development and commercialisation of advanced drug delivery systems, including complex programmes such as autoinjector development.

Dr Rasmussen oversees market expansion and customer engagement for MGS’ A.i.r. Platform™, a customisable device platform based on a modular core technology that enables flexibility across drug, device and patient needs.